Protocol for a randomized controlled trial examining multilevel prediction of response to behavioral activation and exposure-based therapy for generalized anxiety disorder.
J SantiagoE AkemanN KirlicA N ClausenK T CosgroveT J McDermottB MathisM PaulusM G CraskeJ AbelsonC MartellK Wolitzky-TaylorJ BodurkaW K ThompsonRobin Leora AupperlePublished in: Trials (2020)
The study was retrospectively registered within 21 days of first participant enrollment in accordance with FDAAA 801 with ClinicalTrials.gov, NCT02807480. Registered on June 21, 2016, before results.
Keyphrases